Pfizer, BioNTech apply for FDA authorization of Omicron-targeting booster dose
In a statement issued on Monday, the two companies said that data support request for Emergency Use Authorization of a 30yg booster dose of an Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine for individuals 12 years of age and older.
Source: saudigazette.com.sa